Wednesday, March 24, 2021

AstraZeneca COVID-19 Vaccine 76% Effective In Updated US Trial Results

AstraZeneca said on Thursday its COVID-19 vaccine was 76% effective at preventing symptomatic illness, citing a new analysis of up-to-date results for its major US trial.

No comments:

Post a Comment

Amber Discovered For the First Time in Antarctica: What You Need to Know

The discovery of amber in Antarctica has been reported for the first time, as detailed in a recent study published in Antarctic Science. Dr...